@monalisarout1701.bsky.socialGastric cancer advances outlined:
🔬 7.7% cancer deaths worldwide
🔬 69% cases in Asia, high incidence in minorities
🔬 5-year survival varies, 36.4% overall
🔬 HER2 and PD-L1 testing in metastatic cases
#GastricCancer #Oncology #Immunotherapy https://tnyp.me/mkzMBbpw/s
@meducationai.bsky.socialHow much time would it actually take to keep up with oncology research? My honest estimate is in the first ten seconds, and it's more than you'd think.
Here's the AI agent we built to shrink it, free for anyone treating cancer.
@hemehub.bsky.social🌟🔎Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #Immunology #MedicalEducation #MedEd #ClinicalHematology #HemeHub
@hemehub.bsky.social🌟 Our DLBCL case discussion with Sairah Ahmed, MD, and Elif Yilmaz, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/EMPaDlO5lto
@onclive.bsky.social📈 Responses were shown in patients with R/R CLL who had received both a covalent BTK inhibitor and a BCL2 inhibitor, according to a pooled analysis of BRUIN trials.
Read more here ➡️: www.onclive.com/view/pirtobr...
@onclive.bsky.socialOn this Two Onc Docs episode, Samantha A. Armstrong, MD, and @drkarinetawagi.bsky.social host a board-focused review of mNSCLC diagnosis and management. @uofillinois.bsky.social #lcsm #oncology
Listen to the episode on our site or your favorite podcast platforms! www.onclive.com/view/non-sma...
@sroa-radonc.bsky.socialASTRO has issued a statement on the proposed 2027 MPFS and HOPPS rules urging CMS to fix payment policies that undervalue care at independent and freestanding centers. ASTRO also is calling on Congress to pass ROCR. shorturl.at/H7Sj0
@onclive.bsky.social🤔 Lower risks of TLS were shown for venetoclax-based regimens in patients with CLL compared with MCL, according to a real-world analysis.
Full details 📰: onclive.com/view/venetoc...
#leusm #lymsm #oncology #SOHO2026
@societyofhemonc.bsky.social
@onclive.bsky.social📰 The @fda.gov has withdrawn the accelerated approval indication for previously treated adagrasib plus cetuximab for KRAS G12C–mutated mCRC. #crcsm #oncology
See the full story on our site ➡️: www.onclive.com/view/fda-wit...
@onclive.bsky.social🗞️Just in: The FDA has approved a labeling update that reduces the post-infusion monitoring period to 6 to 8 hours following the first two doses of tarlatamab in patients with ES-SCLC #lcsm #oncology
www.onclive.com/view/fda-red...
@aliciaault.bsky.social
@currentmedscience.bsky.socialThis review highlights #sialylation as a key regulator of OC progression, metastasis, and drug resistance, pointing toward novel therapeutic strategies. #medsky
Learn more: doi.org/10.1007/s115...
@fgbonadonna.bsky.socialThe oral RAS(ON) multiselective inhibitor daraxonrasib shows a significantly longer overall survival and progression-free survival in patients with previously treated metastatic pancreatic ductal adenocarcinoma
www.fondazionebonadonna.eu/en/daraxonra...
#FondazioneBonadonna #Oncology #CancerResearch
@cancers-mdpi.bsky.social📢Discover our highly cited #SpecialIssues in #Cancers (2025) related to #molecular cancer biology!
Find out them here📍 www.mdpi.com/journal/canc...
#CancersMDPI #Oncology #CancerBiology #Genetics
@myesmo.bsky.socialDiscover how #pathology helps shape treatment decisions in #oncology.
Join David Rimm, Heike Grabsch, Myrto Moutafi and Maximilian Kloft at the #YO4YO HowTo Virtual Session.
📅 14 Sept 2026, 15:00-16:00 CEST
#ESMOYOC
🔗 ow.ly/uIlV50ZATTP
@cancers-mdpi.bsky.social📸 Great catching up with so many esteemed researchers and experts in the lung cancer community at #WCLC2026!
If you are at the conference, drop by booth #706 to connect with our team! ✨
#LungCancer #CancersMDPI #Oncology @iaslc.bsky.social
@aslamhdfdjygyv.bsky.socialWhat if the next generation of cancer therapies comes from understanding how proteins interact—not just looking at individual proteins?
Read the open-access paper in Nature: www.nature.com/articles/s41...
#CancerResearch #Biotechnology #DrugDiscovery #Oncology #Immunotherapy
@laryngolandotol.bsky.socialCan MRI help diagnose recurrent laryngeal cancer post-radiotherapy? This retrospective review explores its use.
#Radiotherapy #HeadAndNeckCancer #Oncology #Radiology #LaryngealCancer #OpenAccess
@asidejournals.comSuspected Pembrolizumab-Associated Encephalitis Presenting as Altered Mental Status in an Elderly Patient with Cancer: A Case Report
Ezzeddine et al. — ASIDE Oncology
https://asidejournals.com/index.php/oncology/article/view/484
@freegardener.bsky.socialBacteria as cancer drug couriers? Engineered microbes could deliver chemo, radiation & immune drugs straight to tumours—sparing healthy #CancerResearch #DrugDelivery #Oncology #Biotech
https://freegardner.com/sci_scout/bacterial-couriers-for-targeted-cancer-drug-delivery.html